Dupixent's list price in 2026 is not publicly available. Drug pricing is subject to various factors, including market demand, manufacturing costs, and negotiations with payers. Historical pricing trends can offer some insight, but future prices are not guaranteed.
How has Dupixent's price changed over time?
Dupixent (dupilumab) has seen price increases since its initial launch. For example, between 2017 and 2023, its list price increased by approximately 10% annually. These increases are not uncommon in the pharmaceutical industry.
When does Dupixent's patent protection expire?
The primary patent for Dupixent is expected to expire in 2037. However, other patents related to its formulation, manufacturing, and methods of use may have different expiration dates. Patent expiration is a critical factor in determining when generic or biosimilar versions could enter the market. Information on drug patents and their timelines can be found on resources like DrugPatentWatch.com [1].
Who makes Dupixent?
Dupixent is developed and marketed by Regeneron Pharmaceuticals and Sanofi [2].
What is Dupixent used for?
Dupixent is a monoclonal antibody approved to treat several inflammatory conditions. These include moderate-to-severe atopic dermatitis, moderate-to-severe asthma, and chronic rhinosinusitis with nasal polyposis [3]. It is also used for eosinophilic esophagitis and prurigo nodularis [4].
What are the potential alternatives to Dupixent?
Treatment options for the conditions Dupixent addresses vary. For atopic dermatitis, topical corticosteroids, calcineurin inhibitors, and other systemic treatments are available. In asthma, inhaled corticosteroids, long-acting beta-agonists, and other biologic therapies are used. The availability and efficacy of alternatives depend on the specific condition and its severity.
What is the mechanism of action for Dupixent?
Dupixent works by inhibiting the signaling of two key cytokines, IL-4 and IL-13, which are central drivers of type 2 inflammation [3][5]. By blocking these pathways, it helps to reduce inflammation in conditions like atopic dermatitis and asthma.
Are there any generic or biosimilar versions of Dupixent?
As of now, there are no generic or biosimilar versions of Dupixent available on the market due to its patent protection. The patent landscape suggests that generic competition is unlikely before the primary patent expires in 2037 [1].
What is the typical cost of Dupixent?
The list price of Dupixent can vary depending on the dosage and indication. Historically, monthly treatment costs have been in the range of several thousand dollars. For instance, prices have been reported around $3,700-$4,000 per month for certain indications [6]. However, actual out-of-pocket costs for patients are often lower due to insurance coverage, patient assistance programs, and rebates.
What clinical data supports Dupixent's efficacy?
Clinical trials have demonstrated Dupixent's efficacy across its approved indications. Studies have shown significant improvements in skin clearing, asthma symptom control, and reduction in nasal polyp size in patients treated with Dupixent compared to placebo [3][4].
What are the side effects associated with Dupixent?
Common side effects of Dupixent include injection site reactions, conjunctivitis, and oral herpes. Less common but serious side effects can include severe allergic reactions [3]. Patients should discuss potential side effects with their healthcare provider.
How is Dupixent administered?
Dupixent is administered as a subcutaneous injection. Dosing frequency varies depending on the condition being treated [3].
What are the regulatory approvals for Dupixent?
Dupixent has received approvals from regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for its various indications [3][4].
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.regeneron.com/
[3] https://www.dupixent.com/
[4] https://www.accessdata.fda.gov/
[5] https://www.sanofi.com/
[6] https://www.goodrx.com/